• SENSEX
    NIFTY 50
Healthcare

Moderna completes enrollment of phase 2 study of its mRNA COVID-19 vaccine

Updated : July 09, 2020 12:55 AM IST

mRNA-1273 is Moderna’s second mRNA vaccine for an infectious disease to complete enrollment of a Phase 2 study, following the company’s CMV Phase 2 study, which was fully enrolled on March 3, 2020.
Moderna completes enrollment of phase 2 study of its mRNA COVID-19 vaccine

You May Also Like

Live TV
Advertisement